Hanmi to launch Japanese encephalitis live vaccine

Published: 2002-03-28 06:59:00

Updated: 2002-03-28 06:59:00

Hami Pharm says it will launch its imported Japanese encephalitis live vaccine 'CD-Zevax inj' in the middle of next April for the first time in Korea, through a co-marketing with Dongshin Pharm.

CD-Zevax inj. (SA14-14-2) is a Japanese encephalitis vaccine by purifying vaccine virus cultured in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK